Newsletter | September 14, 2020

09.14.20 -- 5 Steps To Prepare For A Third-Party Drug Price Evaluation

 
Sponsor
Magazine Articles
Democratic And Republican Health Priorities In The Next Administration
 

With the conventions and a contentious summer behind them, both political parties are laying out their agendas for the next four years. What are the Democratic and Republican health priorities?

5 Steps To Prepare For A Third-Party Drug Price Evaluation
 

Planning for and mitigating an external review requires proactive team preparation and is crucial to ensure drug success. Here are five steps to take to prepare for evaluations and ensure that your drugs receive reasonable price recommendations.

How Flexion Pivoted To Become A Commercial Biotech
 

Unfortunately, Flexion’s incorporation coincided with the financial crisis of 2007 and 2008, and the assumption that large pharmas would pay premiums for successful proof of concept assets came under pressure.

Public-Private Partnerships Can Lead To Long-Term Success
 

How to plan for, and reap the benefits of, a public-private partnership. Here’s a hint: It won’t be easy.

Web-Exclusive Articles
A Word From Germany On U.S. Manufacturing Productivity
 

Of 367 production plants BASF operates worldwide, six are Verbund sites. Those six produce more than 50 percent of all BASF volumes. A CEO of a U.S.-based CDMO thinks Verbund is the kind of thinking needed at drug development and manufacturing facilities in this country.

Sponsor
Contribute To Life Science Leader
Article Submission Guidelines
 

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. 

Podcasts
The Unusual Backstory Of The MiMedx Cover Feature
 

Ever wonder how a pharma executive gets to be on the cover of Life Science Leader? For Tim Wright, CEO of MiMedx, it was a chance encounter at a leadership conference a few years ago.

September 2020 Digital Edition
 

Inside you will find more on:

  • Companies To Watch
  • Drug Pricing
  • Top Pharma Exec Interviews
  • Industry Research

View the digital edition.